Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease

Stefania Basili, Patrizia Ferroni, Marco Vieri, Patrizia Cardelli, Fabrizio Ceci, Michele Paradiso, Giancarlo Labbadia, Pier Paolo Gazzaniga, Corrado Cordova, Cesare Alessandri

Research output: Contribution to journalArticlepeer-review

Abstract

A recent study has suggested that symptoms of chronic bronchitis predict the risk of coronary disease independently of the known major cardiovascular risk factors. High serum levels of lipoprotein(a) (Lp(a)) have also been considered as an independent risk factor for coronary heart disease. Therefore, the aim of the present study was to investigate the behaviour of Lp(a) in patients affected by chronic obstructive pulmonary disease (COPD). Serum levels of total-cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides, apolipoprotein (Apo) B-100, and Lp(a) were measured in 90 COPD patients and in 90 normal subjects matched for age, sex and smoking habit. COPD patients showed lower serum levels of Apo B-100 (P

Original languageEnglish
Pages (from-to)249-252
Number of pages4
JournalAtherosclerosis
Volume147
Issue number2
DOIs
Publication statusPublished - Sep 9 1999

Keywords

  • Chronic obstructive pulmonary disease
  • Lipoprotein(a)
  • Total cholesterol

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this